PubMed Health⌕ Search

PubMed · 9220869

[Drug administration by inhalation systems].

Abstract

Inhalant systems are often the drug administration method of choice for numerous respiratory diseases. The use of these systems is increasing due to their many advantages, one of which is the small quantity of medication they can deliver to a specific area. However, they also have their disadvantages, as inhalers require certain techniques that are not always followed. Inhalants may be propelled by a variety of methods: pressurized canisters, pumps, dry powder dispensers, nebulizers. Because each of these systems have their own administrating technique, the patient needs to be instructed in the proper use of the inhaler, with periodic follow-ups by health care workers to insure this.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Giner Donaire, M Calpena Irisarri, L Sáiz Martínez, A Blanch Mur. 1997. [Drug administration by inhalation systems].. https://pubmed.ncbi.nlm.nih.gov/9220869/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Concurrent carbogen and radiation therapy in children with high-risk brainstem gliomas.

In an attempt to improve local control, we assessed the feasibility of the addition of 4 min of carbogen inhalation (as a radiosensitizer) to daily fractionated radiotherapy in pediatric patients with high grade and/or diffuse brainstem gliomas. Ten patients inhaled carbogen for >90% of the radiation treatments. Median survival time from start of therapy was 0.80 years. Carbogen inhalation did not appear to improve the dismal prognosis.

Administration, Inhalation↗

2. Advances in pharmacotherapy for COPD.

Chronic obstructive pulmonary disease (COPD) is the most common chronic lung disease in the world. In 1999, COPD ranked sixth among the most common causes of death and twelfth as a worldwide burden of disease. It has been estimated that by the year 2020 COPD will be the third leading cause of death and fifth as a worldwide burden of disease. Thus, COPD is a major medical problem and there is evidence that it is increasing throughout the world. Despite recognition of COPD as an important international health problem, COPD has been neglected among common diseases, with little investment in research on its underlying cellular and molecular mechanisms. Recently, global and Japanese guidelines for COPD have been published. These guidelines seem to be useful to improve the underdiagnosis and undertreatment of COPD. In this review, I describe briefly the current recommendation for pharmacological therapy of stable COPD according to the global and Japanese guidelines for COPD.

Administration, Inhalation↗